Trial Profile

Phase 1b clinical trial assessing SDC-1801 in patients with psoriasis

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 02 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SDC 1801 (Primary)
Indications Psoriasis
Focus Adverse reactions
Sponsors Sareum

Most Recent Events

02 Aug 2022 New trial record
28 Jul 2022 According to Sareum Holdings media release, the CRO conducting and managing the studies has extensive experience in conducting trials in inflammatory diseases and will recruit up to 120 subjects at a site in Manchester, UK.
28 Jul 2022 According to Sareum Holdings media release, a Clinical Trial Authorisation application has been submitted to the UK Medicines and Healthcare Products Regulatory Agency for this trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com